Secura Bio Media

Publications

Published: Oct 30, 2019

PANORAMA-3

A multicenter, randomized, open-label Phase 2 study evaluating the safety and efficacy of three different regimens of oral panobinostat in combination with subcutaneous bortezomib and oral dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma who have been previously exposed to immunomodulatory agents.

View PDF of Protocol »

Link to Publication »